Publications 2021

Kvam AK, Torp HA, Iversen PO (2021)
Life-Threatening Acute Chest Syndrome in a Patient With Sickle Cell Disease After Switching From Hydroxyurea Therapy to Partial Exchange Transfusions: A Case Report
Cureus J Med Sci, 13 (12), e20236
DOI 10.7759/cureus.20236

Tjonnfjord GE, Schjesvold FH, Gulbrandsen N, Kvam AK (2021)
Monoclonal gammopathy of clinical importance
Tidsskr. Nor. Laegeforen., 141 (13), 1276-1280

Publications 2020

Hagestande S, Kvam AK, Lothe IMB, Gjelberg HK, Bruserud O, Tvedt THA (2020)
Aplastic anaemia
Tidsskr. Nor. Laegeforen., 140 (18), 1897-1900

Publications 2016

Barratt-Due A, Floisand Y, Orrem HL, Kvam AK, Holme PA, Bergseth G, Tjonnfjore GE, Mollnes TE (2016)
Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
RHEUMATOLOGY, 55 (7), 1337-1340
DOI 10.1093/rheumatology/kew040

Publications 2015

Kvam AK, Waage A (2015)
Health-related quality of life in patients with multiple myeloma - does it matter?
Haematologica, 100 (6), 704-705
DOI 10.3324/haematol.2015.127860

Publications 2013

Enden T, Wik HS, Kvam AK, Haig Y, Klow NE, Sandset PM (2013)
Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study
BMJ Open, 3 (8), e002984
DOI 10.1136/bmjopen-2013-002984

Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Guldbrandsen N, Haukas E, Carlson K, Kvam AK, Nahi H, Lindas R, Andersen NF, Turesson I, Waage A, Westin J et al. (2013)
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
Blood, 121 (23), 4647-4654
DOI 10.1182/blood-2012-11-464503

Publications 2011

Kvam AK, Fayers PM, Wisloff F (2011)
Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma
Eur. J. Haematol., 87 (4), 330-337
DOI 10.1111/j.1600-0609.2011.01665.x

Publications 2010

Kvam AK, Fayers P, Wisloff F (2010)
What changes in health-related quality of life matter to multiple myeloma patients? A prospective study
Eur. J. Haematol., 84 (4), 345-353
DOI 10.1111/j.1600-0609.2009.01404.x

Kvam AK, Wisloff F, Fayers PM (2010)
Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma
Health Qual. Life Outcomes, 8, 79
DOI 10.1186/1477-7525-8-79

Publications 2009

Kvam AK, Fayers P, Hjermstad M, Gulbrandsen N, Wisloff F (2009)
Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations
Eur. J. Haematol., 83 (4), 279-289
DOI 10.1111/j.1600-0609.2009.01303.x

Publications 2007

Wisloff F, Kvam AK, Hjorth M, Lenhoff S (2007)
Serum calcium is an independent predictor of quality of life in multiple myeloma
Eur. J. Haematol., 78 (1), 29-34
DOI 10.1111/j.0902-4441.2006.t01-1-EJH2887.x